Exelixis
Trade Exelixis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About EXEL
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
The current Exelixis(EXEL) stock price is $42.43, with a market capitalization of 11.38B. The stock trades at a price-to-earnings (P/E) ratio of 17.86.
During the trading session on 2025-11-18, Exelixis(EXEL) shares reached a daily high of $42.62 and a low of $41.15. At a current price of $42.43, the stock is +3.1% higher than the low and still -0.4% under the high.
Trading volume for Exelixis(EXEL) stock has reached 1.06M, versus its average volume of 2.96M.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.
Over the past 52 weeks, Exelixis(EXEL) stock has traded between a high of $49.62 and a low of $31.90.
EXEL News
Wolfe Research analyst Kalpit Patel initiated coverage of Exelixis (EXEL) with a Peer Perform rating and no price target Zanzalintinib is unlikely to fully repl...
Exelixis reported strong third quarter results, raised its earnings guidance for 2025, and announced a new US$750 million share repurchase program, following a...
